Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “At Risk of Type 2 Diabetes Mellitus”

Showing 10 of 0 results

Not applicableStudy completedNCT07386613
What this trial is testing

Feasibility of Home Monitoring of Visual Function in DR

Who this might be right for
Diabetes (DM)Diabetes ComplicationDiabetes (Insulin-requiring, Type 1 or Type 2)+4 more
Queen's University, Belfast 55
Not applicableStudy completedNCT03188263
What this trial is testing

Morning Light Treatment to Improve Glucose Metabolism

Who this might be right for
PreDiabetesCircadian Dysregulation
Northwestern University 10
Large-scale testing (Phase 3)Study completedNCT03151343
What this trial is testing

SGLT-2 Inhibitor and Myocardial Perfusion, Function and Metabolism in T2 DM Patients at High Cardiovascular Risk

Who this might be right for
Type2 Diabetes Mellitus
Caroline M Kistorp 92
Not applicableActive Not RecruitingNCT05000840
What this trial is testing

Integrating Abbott Point-of-Care Technologies and the Community Scientist Model to Support HbA1c Testing Per ADA

Who this might be right for
Diabetes Mellitus, Type 2Cardiovascular Diseases
Sansum Diabetes Research Institute 750
Not applicableStudy completedNCT04937816
What this trial is testing

This Study Combines Data From 3 Other Studies Testing Empagliflozin in Patients With Diabetes or With Chronic Heart Failure. The Study Looks at the Numbers of Patients Who Had Lower Limb Amputations

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 16,746
Not applicableStudy completedNCT05913193
What this trial is testing

Oral Nutritional Supplement in Type 2 Diabetes Subjects With or at Risk of Malnutrition

Who this might be right for
MalnutritionDiabetes
Abbott Nutrition 231
Not applicableUnknownNCT06136013
What this trial is testing

Exercise Timing and the Circadian Clock in Individuals With Type 2 Diabetes and Those at Risk

Who this might be right for
Diabetes Mellitus, Type 2
Faculdade de Motricidade Humana 34
Not applicableStudy completedNCT04281186
What this trial is testing

Retinal and Cognitive Dysfunction in Type 2 Diabetes

Who this might be right for
Retinal FunctionCognitive DysfunctionMicroperimetry
Hospital Universitari Vall d'Hebron Research Institute 510
Testing effectiveness (Phase 2)Study completedNCT01726777
What this trial is testing

Effect of Vitamin D Supplementation on Glucose Tolerance in Subjects at Risk for Diabetes With Low Vitamin D.

Who this might be right for
Type 2 Diabetes MellitusVitamin D Deficiency
University of Toronto 71
Large-scale testing (Phase 3)Ended earlyNCT00549757
What this trial is testing

Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases)

Who this might be right for
Type 2 Diabetes MellitusCardiovascular Disease
Novartis Pharmaceuticals 8,606

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation